Effect of the mitochondrial antioxidant, Mito Vitamin E, on hypoxic-ischemic striatal injury in neonatal rats: a dose-response and stereological study

Exp Neurol. 2006 Jun;199(2):513-9. doi: 10.1016/j.expneurol.2005.12.026. Epub 2006 Feb 14.

Abstract

A mitochondria-targeted antioxidant, Mito Vitamin E (MitoVit E), has previously been shown to prevent mitochondrial oxidative damage. The aim of this study was to investigate the effect of MitoVit E on neuronal survival in the rat striatum after acute perinatal hypoxia-ischemia. Continuous striatal infusion with 4.35 microM, 43.5 microM, or 148 microM of MitoVit E before, during, and after hypoxia-ischemia was not neuroprotective for striatal medium-spiny neurons. Pre- or posttreatment with 435 microM MitoVit E was neurotoxic. These results suggest that MitoVit E is not significantly neuroprotective for striatal medium-spiny neurons after acute perinatal hypoxic-ischemic brain injury. The results also suggest that mitochondrial oxidative damage does not contribute significantly to the death of striatal medium-spiny neurons after perinatal hypoxia-ischemia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Corpus Striatum / drug effects*
  • Corpus Striatum / pathology
  • Dose-Response Relationship, Drug
  • Female
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / pathology
  • Male
  • Pregnancy
  • Rats
  • Rats, Sprague-Dawley
  • Stereotaxic Techniques*
  • Vitamin E / pharmacology
  • Vitamin E / therapeutic use*

Substances

  • Antioxidants
  • Vitamin E